Download PDF
1 / Pages

Other users also viewed these articles

Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease Juan Pablo Arab; Melisa Dirchwolf; Mário Reis Álvares-da-Silva; Francisco Barrera; Carlos Benítez; Marlene Castellanos-Fernandez; Graciela Castro-Narro; Norberto Chavez-Tapia; Daniela Chiodi; Helma Cotrim; Kenneth Cusi; Claudia Pinto Marques Souza de Oliveira; Javier Díaz; Eduardo Fassio; Solange Gerona; Marcos Girala; Nelia Hernandez; Sebastián Marciano; Walter Masson; Nahum Méndez-Sánchez; Nathalie Leite; Adelina Lozano; Martín Padilla; Arturo Panduro; Raymundo Paraná; Edison Parise; Marlene Perez; Jaime Poniachik; Juan Carlos Restrepo; Andrés Ruf; Marcelo Silva; Martín Tagle; Monica Tapias; Kenia Torres; Eduardo Vilar-Gomez; José Eduardo Costa Gil; Adrian Gadano; Marco Arrese;
Ann Hepatol. 2020;19:674-90
Validation of the Hepamet fibrosis score in a multi-ethnic Asian population Shi-En Chong; Felicia Chang; Kee-Huat Chuah; Pavai Sthaneshwar; Nik Raihan Nik Mustapha; Sanjiv Mahadeva; Wah-Kheong Chan;
Ann Hepatol. 2023;28:
Type 2 diabetes mellitus in metabolic-associated fatty liver disease vs. type 2 diabetes mellitus non-alcoholic fatty liver disease: a longitudinal cohort analysis Mark Muthiah; Cheng Han Ng; Kai En Chan; Clarissa Elysia Fu; Wen Hui Lim; Darren Jun Hao Tan; Benjamin Nah; Gwyneth Kong; Jieling Xiao; Jie Ning Yong; Bryan Tan; Nicholas Syn; Jiong-Wei Wang; Nilofer Sayed; Eunice Tan; Nicholas WS Chew; Yock Young Dan; Mohammad Shadab Siddiqui; Arun J. Sanyal; Mazen Noureddin;
Ann Hepatol. 2023;28: